Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1133 of 1,261
  1. EP 1526849

    TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON

    MENARINI FARMA IND [IT] Β· Granted May 4, 2005 Β· Expires Apr 29, 2025

    expired
  2. US 6887866

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  3. US 6887680

    Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

    Precision Therapeutics, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  4. US 6887865

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  5. US 6887466

    Methods for selectively stimulating proliferation of T cells

    United States of America as represented by the Secretary of the Air Force Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  6. US 6887468

    Antibody kits for selectively inhibiting VEGF

    The Board of Regents of the University of Texas System Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  7. US 6887483

    Non-toxic mutants of pathogenic gram-negative bacteria

    The Regents of the University of California Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  8. US 6887902

    Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs

    The Board of Regents of the University of Texas System Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  9. US 6887675

    Tankyrase H, compositions involved in the cell cycle and methods of use

    Rigel Pharmaceuticals, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  10. US 6887489

    Propionibacterium P-63 for use in direct fed microbials for animal feeds

    The Board of Regents for Oklahoma State University Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  11. US 6887845

    Polypeptoid pulmonary surfactants

    Northwestern University Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  12. US 6887976

    Glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  13. US 6889145

    Three-dimensional model of a Fc region of an IgE antibody and uses thereof

    Northwestern University Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  14. US 6887862

    Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy

    Miravant Systems, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  15. US 6887889

    Aryl and biaryl piperdines with MCH modulatory activity

    Pharmacopeia Drug Discovery, Inc. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  16. US 6887920

    Fillings and composite dental materials containing the fillings

    KURARAY CO., LTD. Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  17. US 6887485

    Nitric oxide-releasing metallic medical devices

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 3, 2005 Β· Expires Apr 28, 2025

    expired
  18. WO 2005037272

    DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE

    ARPIDA AS [DK] Β· Granted Apr 28, 2005 Β· Expires Apr 23, 2025

    expired
  19. US 6884888

    Process for the production of N-[3-(3-cyanopyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-N-ethylacetamide (zaleplon)

    Teva Gyogyszergyar Reszvenytarsasag Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired
  20. US 6884871

    Isolation and use of tissue growth-inducing Frzb protein

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired
  21. US 6884239

    Ingestible device for the release of substances at distinct locations in alimentary canal

    Phaeton Research Ltd. Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired
  22. US 6884585

    Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired
  23. US 6884429

    Medical devices incorporating deuterated rapamycin for controlled delivery thereof

    ISOTECHNIKA INTERNATIONAL INC. Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired
  24. US 6884618

    Identification of the gene causing the mouse scurfy phenotype and its human ortholog

    Darwin Discovery Limited Β· Granted Apr 26, 2005 Β· Expires Apr 21, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.